 Our group has developed a practical method for evaluating and getting new insights into inter-individual differences in disease risk and that includes both cancers and common important non-cancer diseases. This method allows us to zero in on DNA sequence changes that contribute in important ways. We're already obtaining novel insights that wouldn't have been achievable by any other strategy.